Showing results (1-10 of 529) with videos related to
Sort By:
Pageof 53
Expert Opinion on Investigational Drugs|January 29, 2020
Benefits and limitations of extended plasma half-life factor VIII products in hemophilia APier Mannuccio MannucciEuropean Journal of Internal Medicine|March 19, 2013
Thromboprophylaxis in the oldest old with atrial fibrillation: between Scylla and CharybdisPier Mannuccio MannucciPathophysiology of Haemostasis and Thrombosis|July 21, 2006
Thrombotic thromboytopenic purpura: another example of immunomediated thrombosisPier Mannuccio MannucciThrombosis and Haemostasis|October 3, 2014
Half-life extension technologies for haemostatic agentsPier Mannuccio MannucciRecenti Progressi in Medicina|April 28, 2023
[Hemophilia therapy in Italy: what the near future promises.]Pier Mannuccio MannucciExpert Opinion on Pharmacotherapy|February 16, 2012
Management of antithrombotic therapy for acute coronary syndromes and atrial fibrillation in patients with hemophiliaPier Mannuccio MannucciHaematologica|August 12, 2021
Thrombotic thrombocytopenic purpura and other immune mediated blood disorders following SARS-CoV-2 vaccinationPier Mannuccio MannucciJournal of Thrombosis and Haemostasis : JTH|March 1, 2023
Hemophilia treatment innovation: 50 years of progress and more to comePier Mannuccio MannucciPageof 53